Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV450
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,216
Award facts
- Contract value 100% obligated
- $12,216.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,216.42 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes (4 mL units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by January 13, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Monovisc is a viscosupplement injection used in orthopedic and rheumatologic treatment for knee osteoarthritis management. This delivery order exemplifies the type of specialized medical commodities and pharmaceutical products that AmerisourceBergen routinely furnishes to federal agencies through its primary IDC with DLA. The award underscores the contractor's critical role in supporting military treatment facilities and Department of Defense healthcare operations by delivering essential medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains consistent capability to meet government requirements through competitive procurement processes and efficient fulfillment of task orders under its established contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FV450?
SPE2DR26FV450 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV450 worth?
The government has obligated $12,216 on SPE2DR26FV450.
Is contract SPE2DR26FV450 an order under another contract?
Yes. SPE2DR26FV450 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV450 competed?
The extent of competition for SPE2DR26FV450 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award